JUSTINE SCHLEIFFELDER: Open Payments
NPI 1356807242 · STONY BROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 19 payments from 11 companies in 2025. Trend: 2023 $531 · 2024 $791 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $71 |
| Novo Nordisk Inc | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Amgen Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 2 | $35 |
| CVRx, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Dexcom G6 Transmitter, ACCRUFER, BREZTRI, Ozempic, KRYSTEXXA, VRAYLAR, AIRSUPRA, OTEZLA.
Industry payments across NY — which companies pay providers there.
